Extract notice to the Minister


Common name / Subject : ixékizumab
Name of the manufacturer : Lilly
Form : Sol. Inj. S.C.
Dosage : 80 mg/mL (1 mL)

Indication : Psoriasis en plaques

INESSS' Recommendation

Minister's decisions
Inscrire aux listes des médicaments - Médicament d’exception

Evaluation published on March 1, 2018

Download Advice to minister about Taltz

 Extrait de l'Avis au ministre sur Taltz 96 KiO

Subscribe to our newsletter now